2WPO
HCMV protease inhibitor complex
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Temperature [K] | 100 |
Spacegroup name | P 21 2 21 |
Unit cell lengths | 107.800, 53.400, 212.400 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 6.000 - 2.700 |
R-factor | 0.226 |
Rwork | 0.226 |
R-free | 0.33200 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1wpo |
RMSD bond length | 0.011 |
RMSD bond angle | 1.600 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | REPLACE |
Refinement software | X-PLOR |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 20.000 |
High resolution limit [Å] | 2.700 |
Rmerge | 0.078 |
Total number of observations | 275527 * |
Number of reflections | 33502 |
Completeness [%] | 93.0 |
Redundancy | 4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | Vapor diffusion, hanging drop * | 7.5 | pH 7.5 |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | drop | protein | 7 (mg/ml) | |
2 | 1 | reservoir | PEG4000 | 18 (%) | |
3 | 1 | reservoir | HEPES | 0.1 (M) | pH7.5 |
4 | 1 | reservoir | 0.2 (M) | ||
5 | 1 | reservoir | glycerol | 10 (%) | |
6 | 1 | reservoir | spermine | 50 (mM) |